Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
58 studies found for:    parkinson's disease AND baylor
Show Display Options
RSS Create an RSS feed from your search for:
parkinson's disease AND baylor
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  MER Versus MRI Guidance DBS in Parkinson's Disease
Condition: Idiopathic Parkinson's Disease (PD)
Intervention:
2 Completed
Has Results
Amitiza in Constipation Associated With PD (Parkinson's Disease)
Condition: Parkinson's Disease
Intervention: Drug: LUBIPROSTONE
3 Completed Trial of Xyrem for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson's Disease (PD)
Condition: Parkinson Disease
Intervention: Drug: sodium oxybate
4 Withdrawn Acamprosate for Treatment of Compulsive Behaviors and Craving in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: acamprosate
5 Completed Namenda (Memantine) for Non-Motor Symptoms in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Memantine;   Drug: placebo
6 Completed Parcopa Versus Carbidopa-Levodopa in a Single Dose Cross-Over Comparison Study
Condition: Parkinson's Disease
Interventions: Drug: Parcopa;   Drug: carbidopa-levodopa
7 Recruiting Study of Urate Elevation in Parkinson's Disease, Phase 3
Condition: Parkinson's Disease
Interventions: Drug: Inosine;   Drug: Placebo
8 Completed Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: Zelapar
9 Active, not recruiting Connect.Parkinson: Connecting Individuals With Parkinson Disease to Specialists in Their Homes
Condition: Parkinson Disease
Intervention: Other: Virtual Visits
10 Recruiting SYN120 a Dual 5-HT6/5-HT2A Antagonist Proof of Concept Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)
Condition: Parkinson's Disease Dementia (PDD)
Interventions: Drug: SYN120;   Drug: Placebo
11 Completed Parkinson's Research: The Organized Genetics Initiative
Condition: Parkinson Disease
Intervention:
12 Completed Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD)
Condition: Parkinson's Disease
Interventions: Drug: PYM50028;   Drug: Placebo
13 Completed
Has Results
An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: IPX066
14 Terminated
Has Results
NET-PD LS-1 Creatine in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: creatine;   Other: placebo
15 Completed
Has Results
Study of Antidepressants in Parkinson's Disease
Conditions: Parkinson Disease;   Depression
Interventions: Drug: paroxetine;   Drug: venlafaxine;   Other: placebo
16 Recruiting Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
Condition: Parkinson Disease
Interventions: Drug: Placebo;   Drug: PF-06649751 low dose;   Drug: PF-06649751 middle dose level 1;   Drug: PF-06649751 middle dose level 2;   Drug: PF-06649751 high dose
17 Completed
Has Results
Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy
Condition: Parkinson's Disease
Interventions: Drug: Carbidopa/levodopa/entacapone;   Drug: Immediate release carbidopa/levodopa
18 Completed
Has Results
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: placebo;   Drug: IPX066
19 Completed Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: fipamezole
20 Completed A Trial to Explore the Potential Benefit of Safinamide on Cognitive Impairment Associated With Parkinson's Disease
Condition: Parkinson's Disease With Cognitive Impairments
Interventions: Drug: safinamide;   Drug: placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years